AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanara MedTech Inc. Director's Dealing 2025

Feb 27, 2025

33339_dirs_2025-02-27_5c55568c-e23c-4abc-8d99-163b8c98412e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2025-02-25

Reporting Person: Taylor Elizabeth B (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-25	Common Stock	A	5382	—	Acquired	5382	Direct

Footnotes

F1: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on February 25, 2026, 2027 and 2028, respectively.